Intrexon Corp at Bank of America Merrill Lynch Health Care Conference Transcript
My name is Mike Ryskin. I'm on the Life Science Tools and Diagnostics team here at Bank of America Merrill Lynch. I'm here on behalf of the Senior Analyst, Derek De Bruin. Unfortunately, he couldn't make it here today, but the show must go on.
So for our next session, we're going to have a short presentation from Intrexon. Joining us today is Randal Kirk, Chairman and CEO. And then towards the end we'll have a brief Q&A session. So Randal, thank you for joining us.
So thank you all for coming. I'm going to be making some statements that may contain some risks and uncertainties, that kind of thing. Read this.
I'm going to, in the interest of time, I'm going to do the last slide first. I want to make sure that we get to -- All right. So is this the last slide? I see. Good.
All right. So what I'd really like you to know for sure, and this is the reason I wanted to go to this slide first, is that
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |